The Safety After Fifty Evaluation trial: Evaluation of the safety and efficacy of antihypertensive therapy with metoprolol in patients 50 to 75 years of age: Study design

Keyphrases

• Hypertension 100%
• Elderly Patients 100%
• Metoprolol 100%
• Antihypertensive Therapy 100%
• Aging Studies 100%
• Evaluation Trial 100%
• Trial Evaluation 100%
• United States 50%
• Illness 50%
• Cardiovascular Disease 50%
• Beneficial Effects 50%
• Plasma Renin Activity 50%
• Physiological Changes 50%
• Drug Metabolism 50%
• Beta-blockers 50%
• Major Risk Factors 50%
• Advancing Age 50%
• Plasma Volume 50%
• Practicing Physicians 50%
• Mild Hypertension 50%
• Hydrochlorothiazide 50%
• Short-term Efficacy 50%
• Drug Side Effects 50%
• Once-daily Regimen 50%
• Antihypertensive Drug Therapy 50%
• Cardioselective 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Metoprolol 100%
• Antihypertensive Therapy 100%
• Renin 50%
• Prevalence 50%
• Pharmacotherapy 50%
• Antihypertensive Agent 50%
• Drug Metabolism 50%
• Adverse Drug Reaction 50%
• Borderline Hypertension 50%
• Hydrochlorothiazide 50%
• Cyclohexanone 50%
• Cardiovascular Disease 50%
• Diseases 50%